

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 8.33155271 |
| 2 | phenol-containing compound catabolic process (GO:0019336) | 7.70739170 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.40922910 |
| 4 | behavioral response to nicotine (GO:0035095) | 6.97639726 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.77987995 |
| 6 | sympathetic nervous system development (GO:0048485) | 6.50947641 |
| 7 | nucleobase catabolic process (GO:0046113) | 5.78855569 |
| 8 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.53894146 |
| 9 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.53894146 |
| 10 | axonal fasciculation (GO:0007413) | 5.42170821 |
| 11 | dendritic spine morphogenesis (GO:0060997) | 5.25276605 |
| 12 | olfactory bulb development (GO:0021772) | 5.15402566 |
| 13 | cell migration in hindbrain (GO:0021535) | 4.95731239 |
| 14 | membrane assembly (GO:0071709) | 4.85063321 |
| 15 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.83322963 |
| 16 | detection of temperature stimulus (GO:0016048) | 4.73244463 |
| 17 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.68585717 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.51188947 |
| 19 | response to pain (GO:0048265) | 4.43143422 |
| 20 | neurotransmitter catabolic process (GO:0042135) | 4.41362799 |
| 21 | neuronal action potential (GO:0019228) | 4.31897092 |
| 22 | behavioral response to ethanol (GO:0048149) | 4.22157840 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.21741876 |
| 24 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.08250987 |
| 25 | positive regulation of mitochondrial fission (GO:0090141) | 4.07724769 |
| 26 | norepinephrine metabolic process (GO:0042415) | 4.04912712 |
| 27 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.98039771 |
| 28 | mitochondrion transport along microtubule (GO:0047497) | 3.98039771 |
| 29 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.97804113 |
| 30 | peripheral nervous system neuron development (GO:0048935) | 3.96516969 |
| 31 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.95594468 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.94002446 |
| 33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.85030696 |
| 34 | neuromuscular synaptic transmission (GO:0007274) | 3.83638805 |
| 35 | neuronal ion channel clustering (GO:0045161) | 3.83384876 |
| 36 | ganglion development (GO:0061548) | 3.82412182 |
| 37 | catecholamine transport (GO:0051937) | 3.76924565 |
| 38 | positive regulation of synapse assembly (GO:0051965) | 3.75797988 |
| 39 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.73494261 |
| 40 | axon extension involved in axon guidance (GO:0048846) | 3.73494261 |
| 41 | auditory behavior (GO:0031223) | 3.71186559 |
| 42 | proline transport (GO:0015824) | 3.69265956 |
| 43 | maternal behavior (GO:0042711) | 3.67455318 |
| 44 | synaptic transmission, cholinergic (GO:0007271) | 3.63189129 |
| 45 | cochlea development (GO:0090102) | 3.63188971 |
| 46 | negative regulation of microtubule polymerization (GO:0031115) | 3.62602388 |
| 47 | layer formation in cerebral cortex (GO:0021819) | 3.61590717 |
| 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.61402570 |
| 49 | cell-cell junction maintenance (GO:0045217) | 3.60355257 |
| 50 | response to water (GO:0009415) | 3.58951034 |
| 51 | dopamine metabolic process (GO:0042417) | 3.58347356 |
| 52 | RNA destabilization (GO:0050779) | 3.55161400 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.52477819 |
| 54 | histone H3-K9 demethylation (GO:0033169) | 3.52236229 |
| 55 | catecholamine biosynthetic process (GO:0042423) | 3.49890745 |
| 56 | catechol-containing compound biosynthetic process (GO:0009713) | 3.49890745 |
| 57 | mechanosensory behavior (GO:0007638) | 3.43874781 |
| 58 | head development (GO:0060322) | 3.43384337 |
| 59 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.42990826 |
| 60 | mannosylation (GO:0097502) | 3.41515095 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.40592115 |
| 62 | positive regulation of gastrulation (GO:2000543) | 3.39759526 |
| 63 | spinal cord association neuron differentiation (GO:0021527) | 3.37240796 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35047748 |
| 65 | axon extension (GO:0048675) | 3.34647622 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.33892258 |
| 67 | dendritic spine organization (GO:0097061) | 3.33000982 |
| 68 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.31638191 |
| 69 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.30062719 |
| 70 | NADH dehydrogenase complex assembly (GO:0010257) | 3.30062719 |
| 71 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.30062719 |
| 72 | central nervous system neuron axonogenesis (GO:0021955) | 3.28962174 |
| 73 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.28856151 |
| 74 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.28856151 |
| 75 | parental behavior (GO:0060746) | 3.28653673 |
| 76 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.26317342 |
| 77 | histone H3-K36 demethylation (GO:0070544) | 3.25846703 |
| 78 | regulation of collateral sprouting (GO:0048670) | 3.25545751 |
| 79 | dendrite morphogenesis (GO:0048813) | 3.25214588 |
| 80 | glutamate secretion (GO:0014047) | 3.25188233 |
| 81 | negative regulation of axon guidance (GO:1902668) | 3.24808466 |
| 82 | neurofilament cytoskeleton organization (GO:0060052) | 3.21959212 |
| 83 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.21870828 |
| 84 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.19196045 |
| 85 | cellular response to nicotine (GO:0071316) | 3.18990121 |
| 86 | synapse assembly (GO:0007416) | 3.18002810 |
| 87 | postsynaptic membrane organization (GO:0001941) | 3.17762625 |
| 88 | regulation of cell maturation (GO:1903429) | 3.16035938 |
| 89 | dendrite development (GO:0016358) | 3.14240114 |
| 90 | cell proliferation in forebrain (GO:0021846) | 3.13966318 |
| 91 | neuron cell-cell adhesion (GO:0007158) | 3.11202501 |
| 92 | enteric nervous system development (GO:0048484) | 3.10417530 |
| 93 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.08668428 |
| 94 | protein polyglutamylation (GO:0018095) | 3.07303316 |
| 95 | cranial nerve morphogenesis (GO:0021602) | 3.05190547 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04917537 |
| 97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04692580 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 3.02264243 |
| 99 | regulation of synapse structural plasticity (GO:0051823) | 3.01558385 |
| 100 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.01276934 |
| 101 | negative regulation of axonogenesis (GO:0050771) | 3.00940622 |
| 102 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00855068 |
| 103 | forebrain neuron differentiation (GO:0021879) | 2.99480246 |
| 104 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.99462557 |
| 105 | adult walking behavior (GO:0007628) | 2.98377224 |
| 106 | negative regulation of dendrite development (GO:2000171) | 2.98111688 |
| 107 | synaptic vesicle maturation (GO:0016188) | 2.97547283 |
| 108 | regulation of feeding behavior (GO:0060259) | 2.97031695 |
| 109 | neurotransmitter secretion (GO:0007269) | 2.96463744 |
| 110 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.94833654 |
| 111 | dopamine receptor signaling pathway (GO:0007212) | 2.94008789 |
| 112 | regulation of dendrite morphogenesis (GO:0048814) | 2.93819102 |
| 113 | retinal ganglion cell axon guidance (GO:0031290) | 2.93027797 |
| 114 | cell differentiation in hindbrain (GO:0021533) | 2.92146413 |
| 115 | retinal cone cell development (GO:0046549) | 2.91929491 |
| 116 | membrane depolarization during action potential (GO:0086010) | 2.91887158 |
| 117 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91700979 |
| 118 | multicellular organismal response to stress (GO:0033555) | 2.90886599 |
| 119 | spinal cord development (GO:0021510) | 2.89199911 |
| 120 | action potential (GO:0001508) | 2.88767386 |
| 121 | protein insertion into membrane (GO:0051205) | 2.88688029 |
| 122 | regulation of vesicle fusion (GO:0031338) | 2.88545091 |
| 123 | negative regulation of amino acid transport (GO:0051956) | 2.87957425 |
| 124 | neuron projection extension (GO:1990138) | 2.87870766 |
| 125 | hippocampus development (GO:0021766) | 2.86272478 |
| 126 | establishment of mitochondrion localization (GO:0051654) | 2.86070393 |
| 127 | regulation of extent of cell growth (GO:0061387) | 2.84261566 |
| 128 | protein localization to synapse (GO:0035418) | 2.83562451 |
| 129 | cardiac ventricle formation (GO:0003211) | 2.83504997 |
| 130 | synaptic transmission, glutamatergic (GO:0035249) | 2.81333046 |
| 131 | clathrin coat assembly (GO:0048268) | 2.80710013 |
| 132 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.80189854 |
| 133 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.80189854 |
| 134 | positive regulation of dendritic spine development (GO:0060999) | 2.79496228 |
| 135 | alanine transport (GO:0032328) | 2.78606100 |
| 136 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.77632574 |
| 137 | establishment of nucleus localization (GO:0040023) | 2.76445977 |
| 138 | neuron migration (GO:0001764) | 2.76103534 |
| 139 | protein complex biogenesis (GO:0070271) | 2.75949228 |
| 140 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75289373 |
| 141 | positive regulation of amino acid transport (GO:0051957) | 2.72400703 |
| 142 | cell junction maintenance (GO:0034331) | 2.71640665 |
| 143 | cardiac chamber formation (GO:0003207) | 2.71012583 |
| 144 | glycine transport (GO:0015816) | 2.70525873 |
| 145 | dopamine biosynthetic process (GO:0042416) | 2.69667640 |
| 146 | epithelial cilium movement (GO:0003351) | 2.68484481 |
| 147 | fear response (GO:0042596) | 2.68480513 |
| 148 | regulation of synapse assembly (GO:0051963) | 2.66171238 |
| 149 | cerebral cortex neuron differentiation (GO:0021895) | 2.65485506 |
| 150 | neurotransmitter transport (GO:0006836) | 2.65434739 |
| 151 | regulation of synaptic vesicle transport (GO:1902803) | 2.65428793 |
| 152 | regulation of neurotransmitter secretion (GO:0046928) | 2.65207272 |
| 153 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65193170 |
| 154 | behavioral response to pain (GO:0048266) | 2.64274691 |
| 155 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.63805517 |
| 156 | sequestering of actin monomers (GO:0042989) | 2.63551302 |
| 157 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.63378628 |
| 158 | regulation of postsynaptic membrane potential (GO:0060078) | 2.63259279 |
| 159 | nonmotile primary cilium assembly (GO:0035058) | 2.63120126 |
| 160 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.63087740 |
| 161 | interferon-gamma production (GO:0032609) | 2.62942614 |
| 162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.62038045 |
| 163 | cranial nerve development (GO:0021545) | 2.61899418 |
| 164 | regulation of axon guidance (GO:1902667) | 2.60745831 |
| 165 | protein localization to cilium (GO:0061512) | 2.60582646 |
| 166 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.60212994 |
| 167 | response to nerve growth factor (GO:1990089) | 2.60212994 |
| 168 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.58881820 |
| 169 | neuronal action potential propagation (GO:0019227) | 2.58529348 |
| 170 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58312240 |
| 171 | neuron recognition (GO:0008038) | 2.58050061 |
| 172 | regulation of microtubule polymerization (GO:0031113) | 2.57534794 |
| 173 | presynaptic membrane organization (GO:0097090) | 10.5879150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.72237581 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.67614290 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.21023636 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.19124480 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04582737 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01382118 |
| 7 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96813109 |
| 8 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.75188123 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.74096006 |
| 10 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.59947881 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58957814 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.56377563 |
| 13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.55243602 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55109454 |
| 15 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52466155 |
| 16 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52466155 |
| 17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45838481 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43744306 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36452798 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36356099 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.33676767 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.33167856 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.31813997 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20775280 |
| 25 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.19834422 |
| 26 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14324942 |
| 27 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09871730 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91225683 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90665811 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89930328 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85822286 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85367239 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.84031208 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83686818 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73882607 |
| 36 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.67799728 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.65033783 |
| 38 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64636686 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64470039 |
| 40 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59865424 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.59729841 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59521109 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.56356148 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54975918 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53899039 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49853797 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47274466 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47191281 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.46178853 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44007507 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42492100 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41063415 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36482902 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35694433 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31408007 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31349842 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31120413 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29473045 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27248155 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26407004 |
| 61 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26363495 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23733388 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23051122 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20875099 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20466462 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19217334 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18706361 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18157454 |
| 69 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17559177 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17374423 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15688501 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14557128 |
| 73 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.14284516 |
| 74 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13408448 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12833955 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11012966 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10590917 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10571455 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09473335 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09007925 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07088826 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06903777 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06185718 |
| 84 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04597941 |
| 85 | JUN_21703547_ChIP-Seq_K562_Human | 1.04022753 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03791091 |
| 87 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03468032 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03124360 |
| 89 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.02813490 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.02415849 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02392700 |
| 92 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02290092 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00051091 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99697233 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99577968 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99340898 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99340898 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99195092 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99034318 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98087378 |
| 101 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98086349 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97512118 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96132158 |
| 104 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95372936 |
| 105 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95041930 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93991729 |
| 107 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93734437 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93577746 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91750603 |
| 110 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91692489 |
| 111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90792711 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90185067 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89820158 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88464434 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87554192 |
| 116 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87310738 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87252703 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86773213 |
| 119 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85894601 |
| 120 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85795065 |
| 121 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85638903 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.85495027 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85488235 |
| 124 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85152044 |
| 125 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84918985 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84324489 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84159919 |
| 128 | AR_19668381_ChIP-Seq_PC3_Human | 0.82915910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 4.93774042 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.77958742 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.34019522 |
| 4 | MP0002736_abnormal_nociception_after | 4.10456007 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.72039634 |
| 6 | MP0004270_analgesia | 3.52871638 |
| 7 | MP0003787_abnormal_imprinting | 3.50099101 |
| 8 | MP0005171_absent_coat_pigmentation | 3.15182836 |
| 9 | MP0002733_abnormal_thermal_nociception | 3.09965631 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 3.01950811 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.98623776 |
| 12 | MP0001970_abnormal_pain_threshold | 2.93777207 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.83640280 |
| 14 | MP0004858_abnormal_nervous_system | 2.80807861 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.70798690 |
| 16 | MP0003121_genomic_imprinting | 2.68814410 |
| 17 | MP0001905_abnormal_dopamine_level | 2.60382445 |
| 18 | MP0009745_abnormal_behavioral_response | 2.57069765 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.44463453 |
| 20 | MP0002751_abnormal_autonomic_nervous | 2.42356139 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.37665120 |
| 22 | MP0002272_abnormal_nervous_system | 2.36794920 |
| 23 | MP0003123_paternal_imprinting | 2.32164848 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 2.30193088 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.12986501 |
| 26 | MP0003890_abnormal_embryonic-extraembry | 2.06827079 |
| 27 | MP0002653_abnormal_ependyma_morphology | 2.04919453 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 2.03306983 |
| 29 | MP0002064_seizures | 2.00922034 |
| 30 | MP0001986_abnormal_taste_sensitivity | 2.00478393 |
| 31 | MP0001188_hyperpigmentation | 1.95372226 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.93408661 |
| 33 | MP0004742_abnormal_vestibular_system | 1.89803896 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.88322031 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.86593836 |
| 36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.82838669 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.81395539 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.71362499 |
| 39 | MP0008995_early_reproductive_senescence | 1.70794040 |
| 40 | MP0008569_lethality_at_weaning | 1.70609523 |
| 41 | MP0008872_abnormal_physiological_respon | 1.67533662 |
| 42 | MP0005409_darkened_coat_color | 1.65564373 |
| 43 | MP0002102_abnormal_ear_morphology | 1.59495818 |
| 44 | MP0002184_abnormal_innervation | 1.55809134 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.55129254 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.43780204 |
| 47 | MP0004924_abnormal_behavior | 1.43780204 |
| 48 | MP0005394_taste/olfaction_phenotype | 1.39427305 |
| 49 | MP0005499_abnormal_olfactory_system | 1.39427305 |
| 50 | MP0000462_abnormal_digestive_system | 1.37989634 |
| 51 | MP0000538_abnormal_urinary_bladder | 1.36862991 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.36849213 |
| 53 | MP0008789_abnormal_olfactory_epithelium | 1.36821402 |
| 54 | MP0003633_abnormal_nervous_system | 1.36015882 |
| 55 | MP0000778_abnormal_nervous_system | 1.33802264 |
| 56 | MP0001529_abnormal_vocalization | 1.32921195 |
| 57 | MP0009046_muscle_twitch | 1.31227266 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.30400135 |
| 59 | MP0003303_peritoneal_inflammation | 1.28948935 |
| 60 | MP0003329_amyloid_beta_deposits | 1.26831606 |
| 61 | MP0001984_abnormal_olfaction | 1.25583738 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.25081049 |
| 63 | MP0003011_delayed_dark_adaptation | 1.25012421 |
| 64 | MP0000955_abnormal_spinal_cord | 1.24858645 |
| 65 | MP0005408_hypopigmentation | 1.23929695 |
| 66 | MP0001486_abnormal_startle_reflex | 1.23314203 |
| 67 | MP0003122_maternal_imprinting | 1.21730248 |
| 68 | MP0005646_abnormal_pituitary_gland | 1.15886845 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.15854121 |
| 70 | MP0003861_abnormal_nervous_system | 1.14480376 |
| 71 | MP0001727_abnormal_embryo_implantation | 1.12911357 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.10318371 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.09614498 |
| 74 | MP0004142_abnormal_muscle_tone | 1.09430372 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.08627624 |
| 76 | MP0003880_abnormal_central_pattern | 1.08030497 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.03653180 |
| 78 | MP0003631_nervous_system_phenotype | 1.03452712 |
| 79 | MP0005391_vision/eye_phenotype | 1.01520619 |
| 80 | MP0000747_muscle_weakness | 0.98872668 |
| 81 | MP0002163_abnormal_gland_morphology | 0.98809329 |
| 82 | MP0005187_abnormal_penis_morphology | 0.98452666 |
| 83 | MP0000534_abnormal_ureter_morphology | 0.97859738 |
| 84 | MP0004133_heterotaxia | 0.97750978 |
| 85 | MP0004885_abnormal_endolymph | 0.94583063 |
| 86 | MP0004130_abnormal_muscle_cell | 0.93495176 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 0.91250889 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.90590434 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.89951773 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.89615168 |
| 91 | MP0003868_abnormal_feces_composition | 0.89560030 |
| 92 | MP0001919_abnormal_reproductive_system | 0.89426375 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.88252035 |
| 94 | MP0005535_abnormal_body_temperature | 0.88136960 |
| 95 | MP0001293_anophthalmia | 0.84649919 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.81760847 |
| 97 | MP0003119_abnormal_digestive_system | 0.81491652 |
| 98 | MP0002160_abnormal_reproductive_system | 0.80226310 |
| 99 | MP0001340_abnormal_eyelid_morphology | 0.80126402 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 0.80047481 |
| 101 | MP0005197_abnormal_uvea_morphology | 0.79918990 |
| 102 | MP0008874_decreased_physiological_sensi | 0.79135778 |
| 103 | MP0000647_abnormal_sebaceous_gland | 0.78960558 |
| 104 | MP0002229_neurodegeneration | 0.78563598 |
| 105 | MP0000920_abnormal_myelination | 0.78271603 |
| 106 | MP0004147_increased_porphyrin_level | 0.77732207 |
| 107 | MP0003879_abnormal_hair_cell | 0.76864759 |
| 108 | MP0005389_reproductive_system_phenotype | 0.76035081 |
| 109 | MP0003938_abnormal_ear_development | 0.75789527 |
| 110 | MP0003942_abnormal_urinary_system | 0.75097674 |
| 111 | MP0002152_abnormal_brain_morphology | 0.74599181 |
| 112 | MP0003634_abnormal_glial_cell | 0.72795400 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.72177835 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.71985491 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.71862022 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.69861788 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.69722936 |
| 118 | MP0001286_abnormal_eye_development | 0.67111578 |
| 119 | MP0002177_abnormal_outer_ear | 0.67069609 |
| 120 | MP0003646_muscle_fatigue | 0.67003884 |
| 121 | MP0000026_abnormal_inner_ear | 0.63339060 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.63127696 |
| 123 | MP0005253_abnormal_eye_physiology | 0.61728360 |
| 124 | MP0003385_abnormal_body_wall | 0.61295959 |
| 125 | MP0000751_myopathy | 0.60929231 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 0.57210521 |
| 127 | MP0000049_abnormal_middle_ear | 0.56518630 |
| 128 | MP0000427_abnormal_hair_cycle | 0.54670781 |
| 129 | MP0005195_abnormal_posterior_eye | 0.52971304 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.51737583 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.50873996 |
| 132 | MP0000604_amyloidosis | 0.50821347 |
| 133 | MP0004134_abnormal_chest_morphology | 0.49601201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 8.12852972 |
| 2 | Retinal dysplasia (HP:0007973) | 5.55129790 |
| 3 | Myokymia (HP:0002411) | 5.14198314 |
| 4 | Abnormal autonomic nervous system physiology (HP:0012332) | 5.13736356 |
| 5 | Retinal atrophy (HP:0001105) | 5.10330809 |
| 6 | Focal motor seizures (HP:0011153) | 4.77707225 |
| 7 | Intestinal atresia (HP:0011100) | 4.75764105 |
| 8 | Orthostatic hypotension (HP:0001278) | 4.45969143 |
| 9 | Buphthalmos (HP:0000557) | 4.10437720 |
| 10 | Anterior segment dysgenesis (HP:0007700) | 4.03921085 |
| 11 | Dysautonomia (HP:0002459) | 3.97075107 |
| 12 | Type II lissencephaly (HP:0007260) | 3.96206379 |
| 13 | Cerebellar dysplasia (HP:0007033) | 3.91714624 |
| 14 | Focal seizures (HP:0007359) | 3.83072688 |
| 15 | Thyroid carcinoma (HP:0002890) | 3.67817880 |
| 16 | Hypoventilation (HP:0002791) | 3.66958265 |
| 17 | Abnormal pancreas size (HP:0012094) | 3.65571524 |
| 18 | Annular pancreas (HP:0001734) | 3.61246688 |
| 19 | Failure to thrive in infancy (HP:0001531) | 3.33923590 |
| 20 | Impaired pain sensation (HP:0007328) | 3.32039983 |
| 21 | Abnormality of pain sensation (HP:0010832) | 3.32039983 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 3.31080793 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.29733021 |
| 24 | Spinal rigidity (HP:0003306) | 3.29363514 |
| 25 | Esophageal atresia (HP:0002032) | 3.26281892 |
| 26 | Polyphagia (HP:0002591) | 3.22632733 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 3.21673202 |
| 28 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 3.21659360 |
| 29 | Difficulty climbing stairs (HP:0003551) | 3.20608923 |
| 30 | Gait imbalance (HP:0002141) | 3.16990390 |
| 31 | Supernumerary spleens (HP:0009799) | 3.15335320 |
| 32 | Pheochromocytoma (HP:0002666) | 3.15080174 |
| 33 | Febrile seizures (HP:0002373) | 3.14621883 |
| 34 | Ulnar claw (HP:0001178) | 3.12473088 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 3.10137371 |
| 36 | Neoplasm of the adrenal cortex (HP:0100641) | 3.01858500 |
| 37 | Abnormality of the aortic arch (HP:0012303) | 3.00985644 |
| 38 | Neonatal hypoglycemia (HP:0001998) | 2.96114639 |
| 39 | Ankle clonus (HP:0011448) | 2.95215159 |
| 40 | Bradycardia (HP:0001662) | 2.93187269 |
| 41 | Visual hallucinations (HP:0002367) | 2.92781922 |
| 42 | Myotonia (HP:0002486) | 2.92013588 |
| 43 | Inability to walk (HP:0002540) | 2.91066655 |
| 44 | Autoamputation (HP:0001218) | 2.90473986 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.87886274 |
| 46 | Congenital primary aphakia (HP:0007707) | 2.86083175 |
| 47 | Hepatoblastoma (HP:0002884) | 2.84595679 |
| 48 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.82996192 |
| 49 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.82231537 |
| 50 | Absent speech (HP:0001344) | 2.81001201 |
| 51 | Abnormality of magnesium homeostasis (HP:0004921) | 2.80748858 |
| 52 | Stomach cancer (HP:0012126) | 2.78513384 |
| 53 | Tented upper lip vermilion (HP:0010804) | 2.76539652 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.74437330 |
| 55 | Renal dysplasia (HP:0000110) | 2.73355434 |
| 56 | Limb dystonia (HP:0002451) | 2.72819592 |
| 57 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.71370585 |
| 58 | Action tremor (HP:0002345) | 2.70653888 |
| 59 | Nemaline bodies (HP:0003798) | 2.70258720 |
| 60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.69770020 |
| 61 | Atonic seizures (HP:0010819) | 2.69106586 |
| 62 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.66307746 |
| 63 | Hypoplasia of the brainstem (HP:0002365) | 2.66307746 |
| 64 | Oligomenorrhea (HP:0000876) | 2.63616653 |
| 65 | Drooling (HP:0002307) | 2.62794288 |
| 66 | Vaginal atresia (HP:0000148) | 2.61585181 |
| 67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.55782390 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.55516374 |
| 69 | Specific learning disability (HP:0001328) | 2.55291286 |
| 70 | Genital tract atresia (HP:0001827) | 2.51007430 |
| 71 | Oligodactyly (hands) (HP:0001180) | 2.50522362 |
| 72 | Termporal pattern (HP:0011008) | 2.49075824 |
| 73 | Insidious onset (HP:0003587) | 2.49075824 |
| 74 | Severe muscular hypotonia (HP:0006829) | 2.48538884 |
| 75 | Congenital glaucoma (HP:0001087) | 2.47488466 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.46548641 |
| 77 | Neoplasm of the adrenal gland (HP:0100631) | 2.46514507 |
| 78 | Anosmia (HP:0000458) | 2.45727633 |
| 79 | Abnormality of midbrain morphology (HP:0002418) | 2.44683926 |
| 80 | Molar tooth sign on MRI (HP:0002419) | 2.44683926 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.43824183 |
| 82 | Asplenia (HP:0001746) | 2.43232954 |
| 83 | Sensory axonal neuropathy (HP:0003390) | 2.42681811 |
| 84 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.42076071 |
| 85 | Chronic hepatic failure (HP:0100626) | 2.39838024 |
| 86 | Excessive salivation (HP:0003781) | 2.38537999 |
| 87 | Nephronophthisis (HP:0000090) | 2.37580146 |
| 88 | Pendular nystagmus (HP:0012043) | 2.36929955 |
| 89 | Amyotrophic lateral sclerosis (HP:0007354) | 2.36905293 |
| 90 | Optic nerve hypoplasia (HP:0000609) | 2.36487132 |
| 91 | Pancreatic fibrosis (HP:0100732) | 2.36380502 |
| 92 | Cortical dysplasia (HP:0002539) | 2.33602649 |
| 93 | Amblyopia (HP:0000646) | 2.32411513 |
| 94 | Occipital encephalocele (HP:0002085) | 2.31442562 |
| 95 | Sclerocornea (HP:0000647) | 2.28196991 |
| 96 | Rib fusion (HP:0000902) | 2.27151077 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.26977605 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.26822898 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 2.26361851 |
| 100 | Intellectual disability, moderate (HP:0002342) | 2.26165503 |
| 101 | Diastasis recti (HP:0001540) | 2.22657343 |
| 102 | Poor coordination (HP:0002370) | 2.22060163 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 2.21554665 |
| 104 | Broad-based gait (HP:0002136) | 2.20536290 |
| 105 | True hermaphroditism (HP:0010459) | 2.17125004 |
| 106 | Urinary urgency (HP:0000012) | 2.16800628 |
| 107 | Volvulus (HP:0002580) | 2.16538738 |
| 108 | Acute encephalopathy (HP:0006846) | 2.15607460 |
| 109 | Scanning speech (HP:0002168) | 2.15502340 |
| 110 | Anxiety (HP:0000739) | 2.13692016 |
| 111 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12950226 |
| 112 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12950226 |
| 113 | Gastrointestinal atresia (HP:0002589) | 2.10445037 |
| 114 | Anophthalmia (HP:0000528) | 2.10134747 |
| 115 | Neuroblastoma (HP:0003006) | 2.10061143 |
| 116 | Primitive neuroectodermal tumor (HP:0030065) | 2.10061143 |
| 117 | Neuroblastic tumors (HP:0004376) | 2.10061143 |
| 118 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.10061143 |
| 119 | Limb-girdle muscle weakness (HP:0003325) | 2.08542601 |
| 120 | Dialeptic seizures (HP:0011146) | 2.08326055 |
| 121 | Epidermoid cyst (HP:0200040) | 2.08125235 |
| 122 | Spastic gait (HP:0002064) | 2.06975300 |
| 123 | Genetic anticipation (HP:0003743) | 2.06497449 |
| 124 | Colon cancer (HP:0003003) | 2.04290892 |
| 125 | Non-midline cleft lip (HP:0100335) | 2.03940606 |
| 126 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.02899641 |
| 127 | Pachygyria (HP:0001302) | 2.01583524 |
| 128 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.01431132 |
| 129 | Anencephaly (HP:0002323) | 2.00723803 |
| 130 | Slender build (HP:0001533) | 2.00509947 |
| 131 | Spastic tetraplegia (HP:0002510) | 2.00005982 |
| 132 | Lissencephaly (HP:0001339) | 1.99984317 |
| 133 | Anomalous pulmonary venous return (HP:0010772) | 1.99269653 |
| 134 | Hyperthyroidism (HP:0000836) | 1.98526285 |
| 135 | Abnormality of the anterior chamber (HP:0000593) | 1.98395971 |
| 136 | Polymicrogyria (HP:0002126) | 1.97555374 |
| 137 | Narrow nasal bridge (HP:0000446) | 1.97437204 |
| 138 | Type 1 muscle fiber predominance (HP:0003803) | 1.97243615 |
| 139 | Growth hormone deficiency (HP:0000824) | 1.96395374 |
| 140 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96077230 |
| 141 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96077230 |
| 142 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94882196 |
| 143 | Ragged-red muscle fibers (HP:0003200) | 1.94063172 |
| 144 | Congenital malformation of the right heart (HP:0011723) | 1.93637394 |
| 145 | Double outlet right ventricle (HP:0001719) | 1.93637394 |
| 146 | Optic disc pallor (HP:0000543) | 1.92778133 |
| 147 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.92017938 |
| 148 | Hyperparathyroidism (HP:0000843) | 1.91856214 |
| 149 | Abnormality of the parathyroid morphology (HP:0011766) | 1.91389394 |
| 150 | Wrist flexion contracture (HP:0001239) | 1.89808218 |
| 151 | Abnormal hair whorl (HP:0010721) | 1.89672368 |
| 152 | Agitation (HP:0000713) | 1.89498951 |
| 153 | Pancreatic cysts (HP:0001737) | 1.89232372 |
| 154 | Abnormal eating behavior (HP:0100738) | 1.88983106 |
| 155 | Exotropia (HP:0000577) | 1.88336498 |
| 156 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87205193 |
| 157 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.86759118 |
| 158 | Severe visual impairment (HP:0001141) | 1.86710069 |
| 159 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.86462696 |
| 160 | Epileptic encephalopathy (HP:0200134) | 1.86432809 |
| 161 | Abnormality of the renal medulla (HP:0100957) | 1.85767401 |
| 162 | Neoplasm of the thyroid gland (HP:0100031) | 1.85344467 |
| 163 | Abnormality of the labia minora (HP:0012880) | 1.80861429 |
| 164 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.76049007 |
| 165 | Oligodactyly (HP:0012165) | 1.75685152 |
| 166 | Status epilepticus (HP:0002133) | 1.74631342 |
| 167 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.74565127 |
| 168 | Abnormality of the vocal cords (HP:0008777) | 1.72673528 |
| 169 | Thyroid-stimulating hormone excess (HP:0002925) | 1.71380032 |
| 170 | Micropenis (HP:0000054) | 1.70353518 |
| 171 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.70037604 |
| 172 | Restlessness (HP:0000711) | 1.69540381 |
| 173 | Postaxial hand polydactyly (HP:0001162) | 1.69368200 |
| 174 | Retinitis pigmentosa (HP:0000510) | 1.69254407 |
| 175 | Attenuation of retinal blood vessels (HP:0007843) | 1.68003053 |
| 176 | Depressed nasal tip (HP:0000437) | 1.67786869 |
| 177 | Labial hypoplasia (HP:0000066) | 1.66492875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 4.66683530 |
| 2 | ADRBK2 | 3.69040451 |
| 3 | CASK | 3.31874489 |
| 4 | DYRK3 | 3.00946364 |
| 5 | CSNK1G3 | 2.96505133 |
| 6 | PNCK | 2.81144287 |
| 7 | LMTK2 | 2.78482038 |
| 8 | GRK5 | 2.78068688 |
| 9 | TRIM28 | 2.61967659 |
| 10 | CSNK1A1L | 2.56629469 |
| 11 | MATK | 2.42785803 |
| 12 | GRK7 | 2.30181521 |
| 13 | CSNK1G2 | 2.30017440 |
| 14 | EPHB2 | 2.20753051 |
| 15 | MARK1 | 2.13903728 |
| 16 | MINK1 | 2.12607477 |
| 17 | DYRK1B | 2.10748457 |
| 18 | CSNK1G1 | 2.04325231 |
| 19 | WNK3 | 1.99949666 |
| 20 | PRPF4B | 1.88848980 |
| 21 | SGK223 | 1.87273731 |
| 22 | SGK494 | 1.87273731 |
| 23 | FES | 1.81037726 |
| 24 | ADRBK1 | 1.80658811 |
| 25 | UHMK1 | 1.78649429 |
| 26 | EPHA4 | 1.76498704 |
| 27 | KSR2 | 1.76325712 |
| 28 | MAP2K1 | 1.76138937 |
| 29 | NTRK3 | 1.70433383 |
| 30 | SGK2 | 1.66540247 |
| 31 | PHKG1 | 1.65958600 |
| 32 | PHKG2 | 1.65958600 |
| 33 | EPHA3 | 1.62340787 |
| 34 | LIMK1 | 1.58542838 |
| 35 | MAP2K7 | 1.54952123 |
| 36 | ARAF | 1.52896382 |
| 37 | MAP3K2 | 1.36778667 |
| 38 | STK16 | 1.36752659 |
| 39 | DYRK1A | 1.34546520 |
| 40 | PLK2 | 1.28035469 |
| 41 | FER | 1.21467604 |
| 42 | RIPK4 | 1.21436106 |
| 43 | MAP3K4 | 1.17918726 |
| 44 | NTRK2 | 1.14066374 |
| 45 | MAPK13 | 1.12688395 |
| 46 | CAMKK1 | 1.11927004 |
| 47 | MAP3K11 | 1.09395437 |
| 48 | FGR | 1.09350970 |
| 49 | EPHB1 | 1.05660992 |
| 50 | MAP3K12 | 1.05498588 |
| 51 | PRKCE | 1.02168426 |
| 52 | TYRO3 | 1.00664823 |
| 53 | PLK4 | 1.00583771 |
| 54 | CDK19 | 0.97794615 |
| 55 | CAMK2G | 0.97441933 |
| 56 | PAK6 | 0.96105533 |
| 57 | MAP4K2 | 0.94901229 |
| 58 | DAPK2 | 0.94429575 |
| 59 | MARK3 | 0.93746038 |
| 60 | WNK1 | 0.92068837 |
| 61 | KSR1 | 0.91714580 |
| 62 | SGK3 | 0.90490162 |
| 63 | SIK3 | 0.88347975 |
| 64 | MAP3K1 | 0.85032655 |
| 65 | CAMK4 | 0.84183521 |
| 66 | AKT3 | 0.83769579 |
| 67 | ERBB2 | 0.83466135 |
| 68 | ERBB3 | 0.82418112 |
| 69 | CDK5 | 0.81335509 |
| 70 | DYRK2 | 0.79614298 |
| 71 | CAMK1G | 0.79552338 |
| 72 | PIK3CA | 0.79402000 |
| 73 | MAPKAPK5 | 0.79165487 |
| 74 | TNIK | 0.77947856 |
| 75 | CAMKK2 | 0.76524720 |
| 76 | SIK2 | 0.76403730 |
| 77 | PRKCG | 0.75934935 |
| 78 | TSSK6 | 0.74989820 |
| 79 | MAP3K6 | 0.74536844 |
| 80 | PINK1 | 0.71060715 |
| 81 | YES1 | 0.70441101 |
| 82 | MAP3K9 | 0.69996139 |
| 83 | ICK | 0.69301831 |
| 84 | BCR | 0.65753397 |
| 85 | CAMK2A | 0.63188436 |
| 86 | PRKCZ | 0.62826932 |
| 87 | MAPK4 | 0.61762112 |
| 88 | INSRR | 0.60045674 |
| 89 | BCKDK | 0.59774528 |
| 90 | PRKACA | 0.58458343 |
| 91 | CSNK1A1 | 0.56523320 |
| 92 | RPS6KA2 | 0.56431366 |
| 93 | TLK1 | 0.56167202 |
| 94 | PLK3 | 0.55134530 |
| 95 | MAPK15 | 0.54540156 |
| 96 | CSNK1E | 0.54341011 |
| 97 | PRKAA1 | 0.53975485 |
| 98 | TESK1 | 0.53546009 |
| 99 | MARK2 | 0.52929096 |
| 100 | OXSR1 | 0.52447876 |
| 101 | ZAK | 0.52200689 |
| 102 | RPS6KB1 | 0.51484346 |
| 103 | SRPK1 | 0.50959953 |
| 104 | STK11 | 0.50220898 |
| 105 | PKN1 | 0.49986417 |
| 106 | PRKG1 | 0.49824443 |
| 107 | CDK14 | 0.49449245 |
| 108 | RET | 0.49399234 |
| 109 | PKN2 | 0.48496805 |
| 110 | CAMK2D | 0.48246244 |
| 111 | STK39 | 0.48200208 |
| 112 | TNK2 | 0.47653078 |
| 113 | STK38 | 0.47196457 |
| 114 | CAMK2B | 0.46186455 |
| 115 | NEK2 | 0.45358231 |
| 116 | PRKCH | 0.43773871 |
| 117 | MAP2K4 | 0.43551526 |
| 118 | IRAK2 | 0.43070419 |
| 119 | PAK3 | 0.41933771 |
| 120 | NME1 | 0.41373386 |
| 121 | PRKACG | 0.39320954 |
| 122 | FRK | 0.37139963 |
| 123 | GRK1 | 0.36970445 |
| 124 | CSNK1D | 0.36932533 |
| 125 | CDK18 | 0.35855622 |
| 126 | MUSK | 0.35170581 |
| 127 | ROCK2 | 0.34947018 |
| 128 | RPS6KA5 | 0.34199997 |
| 129 | DMPK | 0.33944793 |
| 130 | FYN | 0.32161502 |
| 131 | MAPK8 | 0.32080705 |
| 132 | RAF1 | 0.30539038 |
| 133 | MET | 0.30455128 |
| 134 | FLT3 | 0.30264626 |
| 135 | FGFR3 | 0.29986996 |
| 136 | WNK4 | 0.29902806 |
| 137 | HIPK2 | 0.29901655 |
| 138 | CAMK1 | 0.29540999 |
| 139 | CDK15 | 0.29108955 |
| 140 | CDK11A | 0.26270101 |
| 141 | AURKA | 0.26147613 |
| 142 | ROCK1 | 0.24922511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.60750978 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.55850813 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.03845762 |
| 4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.38558870 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.17280560 |
| 6 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.15083522 |
| 7 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09516621 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.07718669 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.00226514 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.97904859 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.96500338 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.95552696 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.95538392 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93047871 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92385498 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86228580 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.85473536 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84825949 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80815806 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.79891733 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72079089 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70966319 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70781365 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.69021654 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68293188 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.68211125 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.65755561 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.65127886 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62479997 |
| 30 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.57788404 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.47850111 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.44723720 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31535095 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29905841 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.29279416 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.25198949 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.24352397 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16762753 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15935431 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09721414 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08667064 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07885443 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.07547552 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03622267 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00414098 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97998553 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97087528 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96132919 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94828782 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94328613 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92453841 |
| 52 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.92217640 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91989226 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90744660 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90135415 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.89872250 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89707848 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87540848 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87023032 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86808521 |
| 61 | Alcoholism_Homo sapiens_hsa05034 | 0.85109275 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84865001 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81945387 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78947510 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77309308 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73810195 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73565779 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73056450 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72734268 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71735859 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71358167 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70797002 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.70640172 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68285957 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66475861 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65958144 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65818305 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.65028487 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63540802 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62833718 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62418964 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60904545 |
| 83 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60103930 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.59210169 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56635851 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56412263 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56050352 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55009210 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53877862 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53728683 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53688618 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52895185 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52847095 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52753684 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52628701 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51794792 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51790212 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51709343 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.51275523 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50924614 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50209910 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49160803 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49148943 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48758917 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48078816 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47977786 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47298270 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46767901 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43632820 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43209048 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42145397 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.42079028 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.41878196 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40956545 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.38309701 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36075178 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.35277433 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34884608 |
| 119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34745512 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34580154 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34178228 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33736260 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33145017 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.32161377 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31773915 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31652404 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.31204048 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31026997 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30971814 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30201487 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30182423 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29636859 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29180074 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29111852 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28691467 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28482809 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28442670 |

